Liposarcoma, Myxoid
Showing 51 - 75 of 113
Sarcoma, Dedifferentiated Liposarcoma Trial in New York (Abemaciclib)
Active, not recruiting
- Sarcoma
- Dedifferentiated Liposarcoma
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Aug 17, 2022
Leiomyosarcoma, Liposarcoma Trial in New York (ATX-101)
Recruiting
- Leiomyosarcoma
- Liposarcoma
-
New York, New YorkColumbia University Irving Medical Center / NewYork-Presbyterian
Nov 23, 2022
Dedifferentiated Liposarcoma Trial in Worldwide (RAIN-32, Trabectedin)
Active, not recruiting
- Dedifferentiated Liposarcoma
-
Palo Alto, California
- +70 more
Aug 4, 2022
Soft Tissue Sarcomas Trial in Zhengzhou (Anlotinib Hydrochloride)
Completed
- Soft Tissue Sarcomas
- Anlotinib Hydrochloride
-
Zhengzhou, Henan, ChinaAffiliated Cancer Hospital of Zhengzhou University&Henan Cancer
Mar 14, 2022
Liposarcoma, Malignant Abdominal Tumor, Malignant Retroperitoneal Tumor Trial in Portland (drug, radiation, other, procedure)
Recruiting
- Liposarcoma
- +5 more
- Eribulin Mesylate
- +5 more
-
Portland, OregonOHSU Knight Cancer Institute
Oct 17, 2022
Advanced Dedifferentiated Liposarcoma Trial in United States (Abemaciclib, Placebo)
Recruiting
- Advanced Dedifferentiated Liposarcoma
- Abemaciclib
- Placebo
-
Jacksonville, Florida
- +6 more
Jul 27, 2022
Adult Patients With Unresectable Locally Advanced or Metastatic, Relapsed/Refractory Dedifferentiated Liposarcoma Trial in
Terminated
- Adult Patients With Unresectable Locally Advanced or Metastatic, Relapsed/Refractory Dedifferentiated Liposarcoma
-
Lille, France
- +5 more
Dec 31, 2020
Solitary Fibrous Tumor, Extraskeletal Myxoid Chondrosarcoma Trial in Spain (Pazopanib)
Active, not recruiting
- Solitary Fibrous Tumor
- Extraskeletal Myxoid Chondrosarcoma
-
Palma De Mallorca, Islas Baleares, Spain
- +6 more
Jan 31, 2022
Dedifferentiated Liposarcoma, Recurrent Dedifferentiated Liposarcoma, Recurrent Undifferentiated Pleomorphic Sarcoma Trial in
Active, not recruiting
- Dedifferentiated Liposarcoma
- +5 more
- Ipilimumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 25, 2022
Liposarcoma, Advanced Solid Tumor Trial in Guangzhou, Shanghai (APG-115, Toripalimab)
Recruiting
- Liposarcoma
- Advanced Solid Tumor
-
Guangzhou, Guangdong, China
- +1 more
Sep 22, 2021
Sarcoma, Melanoma, NSCLC Trial in United States (CMB305, G100, Metronomic CPA)
Terminated
- Sarcoma
- +3 more
- CMB305
- +2 more
-
Santa Monica, California
- +7 more
Jun 29, 2020
Malignant Rhabdoid Tumors (MRT), Rhabdoid Tumors of the Kidney (RTK), Atypical Teratoid Rhabdoid Tumors (ATRT) Trial in
Active, not recruiting
- Malignant Rhabdoid Tumors (MRT)
- +10 more
-
San Francisco, California
- +31 more
Jan 17, 2023
Advanced and / or Metastatic Liposarcoma Trial in Germany, Spain (Pazopanib)
Completed
- Advanced and / or Metastatic Liposarcoma
-
Berlin, Germany
- +14 more
Jul 8, 2020
Sarcoma,Soft Tissue, Nasal Cavity Cancer, Paranasal Sinus Cancer Trial in Shanghai (endoscopic surgery)
Recruiting
- Sarcoma,Soft Tissue
- +3 more
- endoscopic surgery
-
Shanghai, Shanghai, ChinaYu Hongmeng
Nov 7, 2022
Liposarcoma Trial in Nice
Completed
- Liposarcoma
-
Nice, FranceNice Hospital
Oct 15, 2020
Soft Tissue Sarcoma Adult, Advanced Cancer Trial in Beijing (Apatinib)
Withdrawn
- Soft Tissue Sarcoma Adult
- Advanced Cancer
-
Beijing, Beijing, China
- +2 more
May 15, 2020
Soft Tissue Sarcoma Trial in Worldwide (Eribulin mesylate 1.4 mg/m^2 intravenous, Dacarbazine of 850 mg/m^2, or 1,000 mg/m^2, or
Completed
- Soft Tissue Sarcoma
- Eribulin mesylate 1.4 mg/m^2 intravenous
- Dacarbazine of 850 mg/m^2, or 1,000 mg/m^2, or 1,200 mg/m^2 IV
-
Tucson, Arizona
- +118 more
Jul 14, 2020